This inventor holds 1 USPTO granted patent. Top assignee: Clinitech, LLC. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations in Transdermal Technology: The Contributions of Helena Woodvine
Introduction
Helena Woodvine, an inventive mind based in Takoma Park, MD, has made significant strides in the field of biomedical engineering with her innovative work on transdermal sampling and analysis devices. Her notable patent introduces a groundbreaking approach to reduce electrochemical interference in glucose biosensing, ultimately aiming to improve diabetic care.
Latest Patents
Helena is credited with a unique patent titled "Anti-interferent barrier layers for non-invasive transdermal sampling and analysis device." This invention tackles the issue of artificially elevated glucose readings caused by interfering substances in traditional home blood glucose sensors. Her method involves the development of an anti-interferent barrier layer that strategically repels molecules with a similar charge, ensuring more accurate glucose concentration readings. This innovation holds the potential to enhance the reliability of transdermal glucose biosensors significantly.
Career Highlights
Helena Woodvine is associated with Clinitech, LLC, where she continues her research and development in transdermal technologies. Her role reflects a deep commitment to advancing non-invasive medical diagnostics, which is vital for improving patient care.
Collaborations
In her professional journey, Helena has collaborated with talented colleagues such as Joseph J Vidalis and Joseph A Marcanio. Their collective expertise in the field enables groundbreaking developments that push the boundaries of current medical technologies.
Conclusion
Helena Woodvine exemplifies innovation in the biomedical engineering sector, particularly in developing non-invasive glucose monitoring systems. Her contributions to the field, especially through her patented work, stand to make a lasting impact on diabetes management and patient health outcomes. As she continues her work at Clinitech, LLC, the medical community looks forward to what new advancements she will bring.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile